This decreased to a statistically and clinically significant mean rating of 0.89 after the last treatment on the DRX9000.. Were reduces analgesia and reduced activities of daily living improved after treatment with the DRX9000Chronic lower back pain is a common and costly condition in the industrialized countries. A study partially funded by Axiom Worldwide and published online by Pain Practice has shown that chronic low back pain may improve with treatment on the DRX9000. The study, entitled Treatment of 94 outpatients with chronic disc-related low back pain with the DRX9000: A Retrospective Size Chart Review reported that patients with a mean pain duration of 535 weeks a mean verbal numerical pain intensity rating to equal 6.05 0 reported to 10 scale prior to treatment with the DRX9000.
Axiom also provides a digital electrical stimulation device which EPS8000, for use in the relief of pain and for use in muscle rehabilitation. Axiom is subject prides itself on providing safe, non-surgical alternatives that patients think of surgery.. Patients also reported a decrease in the analgesia and improve the activities of daily living.55 on a 10 – point scale. None of these patients reported a need surgery. The authors also recognize that there are other spinal decompression systems available commercially. Proposed, however, lead the design difference between these devices can be different physical responses to therapy, so studies of one type of apparatus should not be used easily in all the machines.Treatment directed with apoptotic mechanisms of, resulted available in limited successful and We hope further studies of autophagy could be perform new approaches to treating of human diseases. .. Since their discovery in the 1960, the programmed cell death had a focal point of research to investigators a broad spectrum of scientific disciplines. An essential mechanism the development and homeostasis of enables in programmed cell death for the clean intracellular destroyed of needless or damaged cells.